Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18454508 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated EXtended Therapy in Hepatitis C Genotype 3 Infected Patients
Condition: Chronic Hepatitis C
Intervention: Drug: Peginterferon alfa-2b (Pegetron) plus ribavirin (Rebetol)

Study has passed its completion date and status has not been verified in more than two years.